Immediate Impact

22 standout
Sub-graph 1 of 11

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
2 intermediate papers

Works of J. Robyn being referenced

Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis
2010
Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion
2007

Author Peers

Author Last Decade Papers Cites
J. Robyn 86 123 19 26 5 169
V. Gallais 102 99 10 21 9 168
Maria I. Edilova 83 128 32 17 6 287
G. Girolomoni 55 84 13 47 5 205
Velia Gerl 59 107 10 13 7 165
Véronique Lamarque 55 182 23 64 7 277
Sandra Mueller‐Schmucker 53 60 9 10 7 169
Athina Matekovits 57 98 26 33 5 234
Taoming Liu 41 125 17 30 7 226
Julian Staniek 40 85 18 13 7 157
Milica Stojakovic 23 125 54 7 9 294

All Works

Loading papers...

Rankless by CCL
2026